# Bioceres Crop Solutions Corp. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Bioceres Crop Solutions Corp.). ## Overview Bioceres Crop Solutions Corp. develops and commercializes agricultural productivity solutions designed to improve crop resilience and soil health. Its business combines patented seed technologies, microbial ag-inputs, and crop nutrition and protection products, with operations and commercial reach centered in Latin America and international markets. ## Products & services • Patented seed technologies and seed traits • Microbial ag-inputs for crop productivity • Crop nutrition products • Crop protection solutions • Climate-resilience agricultural technologies - **Seed technologies** (30%) — Proprietary seed traits and seed-applied technologies that improve crop performance and resilience. - **Microbial ag-inputs** (25%) — Biological inputs such as inoculants and other microbial solutions used to support plant growth. - **Crop nutrition** (20%) — Fertilizer- and nutrient-oriented products that support crop yield and soil management. - **Crop protection** (15%) — Products used to protect crops from pests, diseases, and stress conditions. - **Other agricultural solutions** (10%) — Additional sustainability-oriented and productivity solutions sold through the platform. - Patented seed technologies and seed traits - Microbial ag-inputs for crop productivity - Crop nutrition products - Crop protection solutions - Climate-resilience agricultural technologies ## Customers The company sells to farmers and agricultural producers that need higher-yielding, more resilient crops and input efficiency. It also serves distributors, channel partners, and other stakeholders in the agri-input value chain that commercialize or support these products. Demand is tied to planting cycles, agronomic conditions, and the adoption of technologies that improve productivity under climate stress. - **Farmers and growers** (primary) — Buy seeds, microbial inputs, and crop nutrition/protection products to improve yield and resilience. - **Distributors and dealers** (secondary) — Purchase products for resale and field-level commercialization across local markets. - **Agricultural value-chain partners** (secondary) — Use or distribute technologies that support sustainable and climate-resilient production. - Farmers seeking better crop resilience and yield - Agricultural producers adopting climate-tolerant inputs - Distributors and channel partners reselling ag-inputs - Stakeholders focused on sustainable farming practices - Growers in row-crop and broadacre markets ## Geography Bioceres is headquartered in Argentina and operates with a strong Latin American footprint, while also serving markets beyond its home base. Its commercial exposure is shaped by agricultural cycles, local currency conditions, and country-specific adoption of agri-biotech products. The company’s operational base in Rosario, Argentina, makes South America especially important to its supply chain and commercialization model. - Headquartered in Rosario, Santa Fe, Argentina - Latin America is a core commercial and operating base - International sales extend beyond the home market - Local agriculture cycles affect demand timing - Country exposure matters for currency and trade conditions ## Strategy Bioceres focuses on expanding its biotech platform across seeds, microbial inputs, and next-generation crop nutrition and protection. The company is also emphasizing organizational simplification, working-capital discipline, and capital allocation to support commercialization and cash generation. - **Commercialize proprietary ag-biotech platforms** (medium-term) — Patented technologies can support differentiation and pricing power in input-heavy markets. - **Broaden the product portfolio** (medium-term) — A wider product set increases cross-selling opportunities and reduces reliance on any single solution. - **Improve operating efficiency and capital allocation** (short-term) — Ag-input businesses require disciplined inventory, receivables, and cash management to support growth. - Expand patented biotech-based agricultural solutions - Broaden crop nutrition and protection offerings - Increase adoption of climate-resilience technologies - Improve working capital and cash conversion - Strengthen governance and operating execution ## Risks The business is exposed to agricultural demand cycles, weather variability, and adoption risk around new crop technologies. As a multinational ag-input company, it also faces currency, financing, and execution risk across operating subsidiaries, along with regulatory and product-approval risk common to seed and microbial technologies. - **Agricultural cycle and weather dependence** [high] — Demand for seeds and crop inputs varies with planting decisions, rainfall, and crop conditions. - **Technology adoption risk** [high] — New biotech and microbial products must gain farmer trust and field performance validation. - **Currency and financing exposure** [high] — Cross-border operations and local operating subsidiaries create FX and working-capital sensitivity. - Agricultural demand depends on planting and weather cycles - Adoption of new technologies can be slower than expected - Currency swings affect a cross-border ag business - Working capital needs can strain liquidity in seasonal periods - Regulatory and product-approval hurdles can delay commercialization ## Accounting Bioceres’ results are affected by judgment around working capital, contingent obligations, and transaction-related items, which can move reported earnings materially between periods. The company also uses adjusted EBITDA, so investors should reconcile non-GAAP measures back to IFRS profit or loss and watch how non-cash charges, financing costs, and one-time items affect comparability. - **Adjusted EBITDA reconciliation** — Impacts how investors assess operating performance - **Transaction expenses and contingencies** — Affects period-to-period profit comparability - **Financing costs and interest expense** — Affects net income and earnings quality - Adjusted EBITDA excludes several non-cash and one-time items - Share-based compensation affects GAAP/IFRS comparability - Transaction expenses can distort quarter-to-quarter results - Debt and financing costs can materially affect reported profit - Working-capital related estimates can affect operating metrics --- *Last updated: 2026-09-28T11:57:54.839233+00:00*